|
https://healthimpactnews.com/2022/38983-deaths-and-3530362-injuries-following-covid-shots-in-european-database-as-mass-funeral-for-children-who-died-after-pfizer-vaccine-held-in-switzerland/ 歐洲（歐洲經濟區和非歐洲經濟區國家）疑似藥物反應報告的數據庫是 EudraVigilance，
經歐洲藥品管理局 (EMA) 驗證，他們現在報告注射四次實驗性 COVID-19 疫苗後有
38,983 人死亡，3,530,362 人受傷： 總結受傷和死亡人數如下。 這是截至 2022 年 1 月 29 日的匯總數據。 疫苗來源 | 副作用受傷人數 | 死亡人數 | COVID-19 mRNA 疫苗 MODERNA (CX-024414) | 543，543 | 11，008 | COVID-19 mRNA 疫苗 PFIZER-BIONTECH | 1，704，757 | 17，578 | COVID-19 疫苗阿斯利康 (CHADOX1 NCOV-19) | 1，154，757 | 7，977 | COVID-19 疫苗詹森 (AD26.COV2.S) | 127，305 | 2，420 |
從記錄的傷害總數來看，其中幾乎一半（1,672,872 人）是重傷。
“嚴重性是指以下情況；如果它導致死亡、危及生命、需要住院治療、導致另一種醫學上
重要的疾病或延長現有住院時間、導致持續或嚴重殘疾或喪失能力的醫療事件，或者導致
先天性異常/出生缺陷。則可以將其歸類為“嚴重” ” 歐洲的一位《健康影響新聞》訂閱者
為我們在此處對包括四次 COVID-19 注射的每一種進行了報告。由於我們發現在
EudraVigilance 系統中沒有任何地方可以將所有結果製成表格，因此將每個反應與傷害
和死亡情況製成表格需要做很多工作。 自從我們開始發布此內容以來，來自歐洲的其他人
也計算了這些數字並確認了總數。* 疫苗分類報告： 1） BioNTech/輝瑞公司的
mRNA 疫苗， Tozinameran（代碼 BNT162b2，Comirnaty）的總反應：，
截至 29/01/2022 有 17,578 人死亡和 1,704,757 人受傷 以下各類副作用的症狀和人數： 1）Total reactions for the mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer: 17,578 deaths and 1,704,757 injuries to 29/01/2022
人數 副作用症狀 死亡人數 33,972 Injury, poisoning and procedural complications incl. 331 deaths 42,585 Investigations incl. 502 deaths 11,344 Metabolism and nutrition disorders incl. 273 deaths 201,643 Musculoskeletal and connective tissue disorders incl. 212 deaths 1,629 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 153 deaths 278,744 Nervous system disorders incl. 1,859 deaths 2,513 Pregnancy, puerperium and perinatal conditions incl. 74 deaths 251 Product issues incl. 3 deaths 30,622 Psychiatric disorders incl. 207 deaths 6,150 Renal and urinary disorders incl. 266 deaths 68,129 Reproductive system and breast disorders incl. 6 deaths 72,531 Respiratory, thoracic and mediastinal disorders incl. 1,884 deaths 78,059 Skin and subcutaneous tissue disorders incl. 146 deaths 3,871 Social circumstances incl. 22 deaths 21,010 Surgical and medical procedures incl. 204 deaths 42,532 Vascular disorders incl. 766 deaths
2) Total reactions for the mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 11,008 deaths and 543,543 injuries to 29/01/2022 12,365 Blood and lymphatic system disorders incl. 120 deaths 18,287 Cardiac disorders incl. 1,142 deaths 190 Congenital, familial and genetic disorders incl. 11 deaths 6,310 Ear and labyrinth disorders incl. 8 deaths 502 Endocrine disorders incl. 6 deaths 7,475 Eye disorders incl. 36 deaths 44,340 Gastrointestinal disorders incl. 413 deaths 145,153 General disorders and administration site conditions incl. 3,630 deaths 793 Hepatobiliary disorders incl. 54 deaths 5,370 Immune system disorders incl. 22 deaths 23,070 Infections and infestations incl. 1042 deaths 10,286 Injury, poisoning and procedural complications incl. 208 deaths 12,129 Investigations incl. 393 deaths 4,847 Metabolism and nutrition disorders incl. 263 deaths 66,358 Musculoskeletal and connective tissue disorders incl. 223 deaths 682 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 85 deaths 91,230 Nervous system disorders incl. 1,029 deaths 907 Pregnancy, puerperium and perinatal conditions incl. 10 deaths 98 Product issues incl. 4 deaths 9,441 Psychiatric disorders incl. 181 deaths 3,030 Renal and urinary disorders incl. 214 deaths 12,547 Reproductive system and breast disorders incl. 9 deaths 23,251 Respiratory, thoracic and mediastinal disorders incl. 1,162 deaths 27,540 Skin and subcutaneous tissue disorders incl. 96 deaths 2,239 Social circumstances incl. 45 deaths 3,028 Surgical and medical procedures incl. 203 deaths 12,075 Vascular disorders incl. 399 deaths
3) Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 7,977 deaths and 1,154,757 injuries to 29/01/2022 13,912 Blood and lymphatic system disorders incl. 278 deaths 20,984 Cardiac disorders incl. 830 deaths 235 Congenital familial and genetic disorders incl. 8 deaths 13,406 Ear and labyrinth disorders incl. 7 deaths 692 Endocrine disorders incl. 6 deaths 20,086 Eye disorders incl. 32 deaths 107,453 Gastrointestinal disorders incl. 434 deaths 304,993 General disorders and administration site conditions incl. 1,855 deaths 1,039 Hepatobiliary disorders incl. 69 deaths 5,409 Immune system disorders incl. 40 deaths 42,266 Infections and infestations incl. 620 deaths 13,630 Injury poisoning and procedural complications incl. 198 deaths 25,681 Investigations incl. 205 deaths 13,023 Metabolism and nutrition disorders incl. 126 deaths 168,174 Musculoskeletal and connective tissue disorders incl. 165 deaths 743 Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 40 deaths 234,117 Nervous system disorders incl. 1,178 deaths 635 Pregnancy puerperium and perinatal conditions incl. 20 deaths 199 Product issues incl. 1 death 21,051 Psychiatric disorders incl. 69 deaths 4,338 Renal and urinary disorders incl. 78 deaths 16,849 Reproductive system and breast disorders incl. 3 deaths 41,401 Respiratory thoracic and mediastinal disorders incl. 1,082 deaths 52,064 Skin and subcutaneous tissue disorders incl. 65 deaths 1,617 Social circumstances incl. 9 deaths 1,973 Surgical and medical procedures incl. 30 deaths 28,787 Vascular disorders incl. 529 deaths
4) Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 2,420 deaths and 127,305 injuries to 29/01/2022 1,229 Blood and lymphatic system disorders incl. 51 deaths 2,552 Cardiac disorders incl. 204 deaths 40 Congenital, familial and genetic disorders incl. 1 death 1,319 Ear and labyrinth disorders incl. 3 deaths 105 Endocrine disorders incl. 1 death 1,656 Eye disorders incl. 10 deaths 9,588 Gastrointestinal disorders incl. 88 deaths 34,487 General disorders and administration site conditions incl. 685 deaths 153 Hepatobiliary disorders incl. 13 deaths 544 Immune system disorders incl. 10 deaths 8,521 Infections and infestations incl. 207 deaths 1,147 Injury, poisoning and procedural complications incl. 25 deaths 6,086 Investigations incl. 131 deaths 756 Metabolism and nutrition disorders incl. 60 deaths 17,116 Musculoskeletal and connective tissue disorders incl. 55 deaths 86 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 8 deaths 23,413 Nervous system disorders incl. 245 deaths 55 Pregnancy, puerperium and perinatal conditions incl. 1 death 30 Product issues 1,766 Psychiatric disorders incl. 22 deaths 535 Renal and urinary disorders incl. 31 deaths 2,941 Reproductive system and breast disorders incl. 6 deaths 4,468 Respiratory, thoracic and mediastinal disorders incl. 304 deaths 3,760 Skin and subcutaneous tissue disorders incl. 10 deaths 409 Social circumstances incl. 4 deaths 867 Surgical and medical procedures incl. 74 deaths 3,676 Vascular disorders incl. 171 deaths
*These totals are estimates based on reports submitted to EudraVigilance. Totals may be much higher based on percentage of adverse reactions that are reported. Some of these reports may also be reported to the individual country’s adverse reaction databases, such as the U.S. VAERS database and the UK Yellow Card system. The fatalities are grouped by symptoms, and some fatalities may have resulted from multiple symptoms. 還有圖片視頻無法上傳，感興趣者請自行點擊鏈接查閱
|
|
